Patent details
EP1137941
Title:
PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS
Basic Information
- Publication number:
- EP1137941
- PCT Application Number:
- PCT/US/1999/029317
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP999672611
- PCT Publication Number:
- WO/2000/034784
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS
- French Title of Invention:
- ECHAFAUDAGES DE PROTEINES POUR DES MIMES D'ANTICORPS ET AUTRES PROTEINES DE LIAISON
- German Title of Invention:
- PROTEINGERÜSTE FÜR ANTIKÖRPER-NACHAHMER UND ANDERE BINDENDE PROTEINE
- SPC Number:
-
Dates
- Filing date:
- 09/12/1999
- Grant date:
- 12/08/2009
- EP Publication Date:
- 12/08/2009
- PCT Publication Date:
- 15/06/2000
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/10/2001
- EP B1 Publication Date:
- 12/08/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/12/2017
- Expiration date:
- 09/12/2019
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/12/1999
-
-
- Name:
- Bristol-Myers Squibb Company
- Address:
- Route 206 and Province Line Road, Princeton NJ 08543-4000, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 09/09/2009
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
- Name:
- LIPOVSEK Dasa
- Address:
- United States (US)
Priority
- Priority Number:
- 111737 P
- Priority Date:
- 10/12/1998
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
G01N 33/536;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 28/11/2016
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- MARKS & CLERK LLP